Affiliations 

  • 1 P W K Chan, MPaeds. Division of Respiratory Medicine, University Malaya Medical Center, 50603 Kuala Lumpur
  • 2 M Z Norzila, MPaeds. Respiratory Unit, Insititut Pediatrik, 53000 Kuala Lumpur
Med J Malaysia, 2003 Oct;58(4):475-81.
PMID: 15190621

Abstract

The treatment preferences of 109 general practitioners (GPs) for childhood asthma were determined. Availability and adherence to clinical practice guidelines (CPG) for the treatment of childhood asthma was also assessed. Ninety eight (90%), 60 (55%) and 33 (30%) GPs considered nocturnal symptoms > 2 times/week, exercise induced wheeze and cough respectively as indications for preventer therapy. An oral preparation was preferred for relief medication [72 (66%) for 2-5 years, 60 (55%) for > 5 years]. An inhaled preparation was however preferred for preventer medication [60 (55%) for 2-5 years, 85 (78%) for > 5 years]. The oral form was more likely prescribed for asthmatic children 2-5 years (p < 0.001). Corticosteroids and ketotifen were the commonest inhaled and oral preventer treatment prescribed respectively. Only 36(33%) GPs have a CPG copy for reference. Children with asthma symptoms that require preventer therapy may not always be identified in general practice. The oral route remains important for asthma medication especially in young children. The accessibility to the CPG among GPs is disappointing.
Study site: General practitioners attending a pharmaceutical industry sponsored asthma management workshop

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.